Juan A. Parga

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Renin-angiotensin system as an emerging target to modulate adult neurogenesis in health and disease.

Renin-angiotensin system as an emerging target to modulate adult neurogenesis in health and disease.

Journal: Stem cell research & therapy
Published: December 26, 2024

Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson's disease models.

Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson's disease models.

Journal: Stem cell research & therapy
Published: December 20, 2023

Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells.

Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells.

Journal: Neural regeneration research
Published: August 26, 2022

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene.

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 25, 2022

NRF2 Activation and Downstream Effects: Focus on Parkinson's Disease and Brain Angiotensin.

NRF2 Activation and Downstream Effects: Focus on Parkinson's Disease and Brain Angiotensin.

Journal: Antioxidants (Basel, Switzerland)
Published: September 27, 2021

Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model.

Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model.

Journal: Journal of cellular and molecular medicine
Published: July 15, 2021

Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions.

Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions.

Journal: Stem cells (Dayton, Ohio)
Published: March 29, 2021

Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular-Subventricular Zone.

Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular-Subventricular Zone.

Journal: Cells
Published: October 28, 2019

Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines.

Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines.

Journal: Data in brief
Published: October 10, 2018

Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells.

Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells.

Journal: Free radical biology & medicine
Published: July 17, 2018

Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.

Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.

Journal: Molecular neurobiology
Published: August 12, 2017

Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Journal: Molecular neurobiology
Published: April 03, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026